Investigating how complement activation affects kidney injury in sepsis
Complement Activation in Sepsis
This study is looking at how a certain protein in urine might help doctors predict kidney problems in people with sepsis, so they can find better ways to protect the kidneys in seriously ill patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11142429 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of complement activation in sepsis-associated acute kidney injury (SA-AKI), a serious condition affecting both children and adults. The study will enroll critically ill patients diagnosed with sepsis and measure levels of a specific protein, urine complement factor Ba, to see if it can predict the onset of kidney injury. By collecting and analyzing urine samples over time, researchers aim to establish a link between elevated urine Ba levels and severe kidney outcomes. The findings could pave the way for future therapeutic trials targeting complement activation to prevent kidney damage in sepsis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include critically ill children and adults diagnosed with sepsis.
Not a fit: Patients who do not have sepsis or those with chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new methods for predicting and potentially preventing kidney injury in patients with sepsis.
How similar studies have performed: Previous research has shown promising results in understanding the role of complement activation in kidney injury, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Stenson, Erin K — University of Colorado Denver
- Study coordinator: Stenson, Erin K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.